Top Monte dei Paschi investor backs Intesa’s sweetened €34.5bn takeover bid - Financial Times

Marco Rubio still owes Europe answers about America’s intentions - Financial Times

2026-10-25

Ivonescimab Plus Chemotherapy Demonstrates Overall Survival Superiority Compared to Durvalumab Plus Chemotherapy in Firs

2026-10-25

Sonesitatug vedotin reduced the risk of death by 42% in 2nd and later-line CLDN18.2-positive advanced gastric/GEJ cancer

2026-10-25

Positive Overall Survival Results from the Phase III HARMONi-GI1 Trial of Ivonescimab Plus Chemotherapy Versus Durvaluma

2026-10-25

TAGRISSO® (osimertinib) plus savolitinib reduced the risk of disease progression or death by 45% and the risk of death b

2026-10-25